T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UMH
1326
UMH Properties
UMH
$1.39B
| $16.2M | ﹤0.01% |
593,720
+81,369
| +16% | +$1.96M |
|
|
THRX
1327
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $16.2M | ﹤0.01% |
+1,299,487
| New | +$19.6M |
|
1328
W.R. Berkley
WRB
$25.9B
| $16.1M | ﹤0.01% |
438,406
-21,188
| -5% | -$751K |
|
|
AGFS
1329
DELISTED
AgroFresh Solutions Inc
AGFS
| $15.9M | ﹤0.01% |
7,982,167
-39,946
| -0.5% | -$79.5K |
|
1330
Saga Communications
SGA
$64.6M
| $15.8M | ﹤0.01% |
657,258
| – | – |
|
1331
NRG Energy
NRG
$25.4B
| $15.7M | ﹤0.01% |
363,712
-19,701
| -5% | -$774K |
|
1332
Restaurant Brands International
QSR
$26.1B
| $15.6M | ﹤0.01% |
257,462
+1,000
| +0.4% | +$58.9K |
|
|
VSXY
1333
Victoria's Secret
VSXY
$7.39B
| $15.6M | ﹤0.01% |
280,849
-2,106
| -0.7% | -$110K |
|
1334
Universal Health Services
UHS
$10.2B
| $15.2M | ﹤0.01% |
116,974
-18,686
| -14% | -$2.4M |
|
1335
Supernus Pharmaceuticals
SUPN
$2.78B
| $15.1M | ﹤0.01% |
516,921
-5,309
| -1% | -$161K |
|
1336
Petrobras
PBR
$115B
| $14.9M | ﹤0.01% |
1,354,383
-403,420
| -23% | -$4.26M |
|
1337
TETRA Technologies
TTI
$1.29B
| $14.7M | ﹤0.01% |
5,186,733
-39,000
| -0.7% | -$120K |
|
1338
Recursion Pharmaceuticals
RXRX
$1.78B
| $14.7M | ﹤0.01% |
857,573
+276,903
| +48% | +$5.21M |
|
1339
JetBlue
JBLU
$2.19B
| $14.6M | ﹤0.01% |
1,028,285
+499,419
| +94% | +$7.34M |
|
1340
Chewy
CHWY
$9.15B
| $14.6M | ﹤0.01% |
248,183
-78,139
| -24% | -$5.11M |
|
1341
Zions Bancorporation
ZION
$10.5B
| $14.6M | ﹤0.01% |
230,412
-21,204
| -8% | -$1.35M |
|
|
SIX
1342
DELISTED
Six Flags Entertainment Corp.
SIX
| $14.5M | ﹤0.01% |
339,538
-4,557
| -1% | -$190K |
|
1343
Arcosa
ACA
$7.12B
| $14.4M | ﹤0.01% |
273,917
-1,954
| -0.7% | -$104K |
|
1344
Rigetti Computing
RGTI
$6.21B
| $14.4M | ﹤0.01% |
+1,398,000
| New | +$14.6M |
|
1345
Ormat Technologies
ORA
$6.97B
| $14.3M | ﹤0.01% |
180,829
-79,390
| -31% | -$5.99M |
|
1346
Palantir
PLTR
$430B
| $14.1M | ﹤0.01% |
776,738
+23,890
| +3% | +$528K |
|
1347
SEACOR Marine Holdings
SMHI
$264M
| $14.1M | ﹤0.01% |
4,133,266
+4,804
| +0.1% | +$20.8K |
|
1348
Globe Life
GL
$13.8B
| $14M | ﹤0.01% |
148,903
-7,752
| -5% | -$717K |
|
1349
IPG Photonics
IPGP
$3.71B
| $13.9M | ﹤0.01% |
80,955
-976
| -1% | -$161K |
|
1350
RGC Resources
RGCO
$225M
| $13.9M | ﹤0.01% |
605,036
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.